10/10/2013

The Indian drug manufacturer Bliss GVS acknowledged delays in obtaining product registrations through a local partner for its anti-malarial medicine Gsunate Plus, but rejected allegations that the drug is fake and called the Ghanaian ban on its products "harsh" and "baffling."

Related Summaries